Skandinaviska Enskilda Banken (SEB)’s Lunai Bioworks LNAI Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28	Closed	-$19K	–	1057
2022 Q1	$19K	Hold	28	–	–	﹤0.01%	971
2021 Q4	$17K	Hold	28	–	–	﹤0.01%	970
2021 Q3	$15K	Hold	28	–	–	﹤0.01%	994
2021 Q2	$11K	Hold	28	–	–	﹤0.01%	1028
2021 Q1	$8K	Hold	28	–	–	﹤0.01%	1104
2020 Q4	$7K	Hold	28	–	–	﹤0.01%	1117
2020 Q3	$8K	Hold	28	–	–	﹤0.01%	1008
2020 Q2	$9K	Sell	28 -68	-71%	-$20.5K	﹤0.01%	1042
2020 Q1	$23K	Buy	96 +46	+92%	+$13.7K	﹤0.01%	895
2019 Q4	$20K	Buy	50 +12	+32%	+$5.28K	﹤0.01%	913
2019 Q3	$17K	Buy	+38	New	+$14.5K	﹤0.01%	895

Other funds holding LNAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s LNAI Position: Q2 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Lunai Bioworks (LNAI) in Q2 2022, closing a stake of 28 shares — an estimated $19K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in LNAI in Q3 2019 and held it in 11 quarters. The position peaked at $23K in Q1 2020. 51 funds tracked by Wall St. Rank hold LNAI as of Q2 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining Lunai Bioworks position as of Q2 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 28 Lunai Bioworks shares in Q2 2022, an estimated $19K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Lunai Bioworks in Q3 2019 and held it in 11 quarters.
Skandinaviska Enskilda Banken (SEB)'s Lunai Bioworks position peaked at $23K in Q1 2020.
51 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2022, filed 10 Aug 2022.